...financial terms, and Insero did not respond to inquiries. Biscayne Pharmaceuticals Inc. , Miami, Fla. Insero Health Inc....

...Mnemosyne Pharmaceuticals Inc. has GRIN2A-selective NMDAR modulators in preclinical development for schizophrenia, depression and autism. Insero Health Inc....

...electrical stability. Data were presented at the Antiepileptic Drug and Device Trials meeting in Aventura. Insero Health Inc....

...of the rats. Next steps include characterizing huperzine A in additional rodent models of SCI. Insero Health Inc....
...page 4). SciBX 6(7); doi:10.1038/scibx.2013.170 Published online Feb. 21, 2013 Findings patented; exclusively licensed to Insero Health...

...small molecule huperzine A can reduce neuropathic pain in rats with spinal cord injury. 1 Insero Health Inc....
...professor of neurology at Harvard Medical School and chairman of the scientific advisory board for Insero Health...
...Published online Feb. 21, 2013 Companies and Institutions Mentioned Harvard Medical School , Boston, Mass. Insero Health Inc....

...manufacturing process for huperzine, a compound derived from a botanical extract. Details were not disclosed. Insero Health Inc....